Logo
S

Slingshot Biosciences

71 employees

At Slingshot Biosciences, we’re transforming cell-based applications with the most robust, scalable, and reproducible cell mimics including TruCytes™ Biomarker controls, SpectraComp® compensation controls, ViaComp® cell health controls, and FlowCytes® instrument controls. Our TruCytes cell mimics precisely replicate real cells' optical and biochemical properties—without the quality, sourcing, or cost challenges of traditional controls. Trusted in cell-based applications across cell therapy, drug development, and diagnostics, they empower process and analytical development, quality control, potency assessments, multi-site validations, clinical research studies, and assay development and validation. Accelerate your research and elevate your cell-based assays with our shelf-stable, on-demand cell mimic solutions that deliver breakthrough reproducibility, scalability, and cost-effectiveness. Learn more at slingshotbio.com.

Investor insights

Funding rounds participated in

$15M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2012

Funding rounds raised

Total raised

$15M

from 2 investors over 1 rounds

S

Slingshot Biosciences raised $15M on May 26, 2024

Investors: Anterra Capital and + 3 Other investors

FAQ